Univest
Univest
  • Markets

Jupiter Life Line Hospitals (JLHL) Share Price Rises 9.7% Today

  • November 20, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Jupiter Life Line Hospitals Share Price
Jupiter Life Line Hospitals Ltd. (JLHL) share price rose to Rs 308.05 today, up 9.7% from the previous close. Market cap was Rs 9,493.96 crore.

Jupiter Life Line Hospitals Share Price is trading at Rs 308.05 after a 9.7% rise today, and the company’s market capitalisation stands at Rs 9,493.96 crore. The move leaves JLHL in focus among stocks in news in the Indian stock market, even though no company-specific catalyst is established. According to latest Univest data, the rise is fully visible in the price action: the stock opened at Rs 281.35, moved through the day’s range, and was last traded at the day’s high of Rs 308.05 as of 20 November 2026 at 1:23:03 PM IST. For readers tracking Jupiter Life Line Hospitals Share Price today, the event is relevant because the move comes with a clear valuation profile, sector benchmark context and peer comparison that can be reviewed without speculation. The latest Univest figures also show why investors are likely to monitor JLHL Share Price news alongside healthcare sector trends.

Table of Contents

Toggle
  • Jupiter Life Line Hospitals Share Price Today: Price Action Analysis
  • Jupiter Life Line Hospitals Ltd. (JLHL) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Jupiter Life Line Hospitals
  • About Jupiter Life Line Hospitals
  • Frequently Asked Questions
    • Why is Jupiter Life Line Hospitals Share Price rising today?
    • What is Jupiter Life Line Hospitals Share Price today?
    • What was the previous close for JLHL Share Price?
    • What does Jupiter Life Line Hospitals Fundamental Analysis show?
    • How does Jupiter Life Line Hospitals compare with healthcare peers?
    • What is the market cap of Jupiter Life Line Hospitals?
    • Is Jupiter Life Line Hospitals part of NSE and BSE?
    • What sector benchmark is relevant for Jupiter Life Line Hospitals?
  • Track Jupiter Life Line Hospitals Share Price on Univest

Jupiter Life Line Hospitals Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 308.05
Previous Close Rs 280.8
Today's Move Rs 27.25 (+9.7%)
Open Rs 281.35
High Rs 308.05
Low Rs 281.35
Market Capitalisation Rs 9,493.96 crore
Market Cap Category Mid Cap

Jupiter Life Line Hospitals Ltd. (JLHL) rose to Rs 308.05 from the previous close of Rs 280.8, a move of Rs 27.25 or 9.7%. The stock opened at Rs 281.35, reached a high of Rs 308.05, recorded a low of Rs 281.35.

Jupiter Life Line Hospitals Share Price is up sharply today, with the stock last traded at Rs 308.05 after adding Rs 27.25 over the previous close of Rs 280.8. The move equals 9.7% and places the stock at the day’s high, after opening at Rs 281.35 and touching a low of Rs 281.35. Jupiter Life Line Hospitals Share Price therefore shows a clean intraday advance rather than a late reversal. For investors following JLHL Share Price Today, the numbers point to a straightforward price rise in an active healthcare name, with the market capitalisation now at Rs 9,493.96 crore. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes the move a data-led event for stock analysis rather than a narrative-led one, and it naturally leads into the company’s financial profile.

Jupiter Life Line Hospitals Ltd. (JLHL) Fundamental Analysis

Metric Value
Market Capitalisation Rs 9,493.96 crore
P/E Ratio 49.38x
P/B Ratio 5.65x
ROE 13.39%
ROCE 15.7%
EPS Rs 5.69
Book Value Per Share Rs 49.73
Dividend Yield 0.07%

Jupiter Life Line Hospitals Ltd. (JLHL) fundamental metrics show P/E 49.38x, P/B 5.65x, ROE 13.39%, ROCE 15.7%. These ratios show where the company stands today and are not a call to buy or sell.

Jupiter Life Line Hospitals Ltd. has a market capitalisation of Rs 9,493.96 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.38x, P/B at 5.65x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.39% and ROCE of 15.7%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.69, book value per share of Rs 49.73, dividend yield of 0.07%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.48x, median ROE of 12.88%, median ROCE of 15.43%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 49.38x
Benchmark Median P/E 44.48x
Benchmark Average P/E 72.94x
Benchmark P/E Range 5.24x to 812.44x
Company P/B Ratio 5.65x
Benchmark Median P/B 3.61x
Company ROE 13.39%
Benchmark Median ROE 12.88%
Company ROCE 15.7%
Benchmark Median ROCE 15.43%
Company Market Capitalisation Rs 9,493.96 crore
Benchmark Median Market Cap Rs 582.69 crore

Jupiter Life Line Hospitals Ltd. (JLHL) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Jupiter Life Line Hospitals Ltd. (JLHL) has a P/E ratio of 49.38x, which is above the benchmark median of 44.48x, a difference of +11.02%. A P/E difference of this kind is a reference point rather than a recommendation.

Jupiter Life Line Hospitals Ltd. (JLHL) has a ROE of 13.39%, which is above the benchmark median of 12.88%, a difference of +3.96%. Jupiter Life Line Hospitals Ltd. (JLHL) has a ROCE of 15.7%, which is above the benchmark median of 15.43%, a difference of +1.75%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Apollo Hospitals Enterprise Ltd. APOLLOHOSP 1,26,688.66 56.08 11.86 23.54 21.73
Max Healthcare Institute Ltd. MAXHEALTH 99,474.02 73.2 8.92 14.53 14.97
MANIPAL HEALTH ENTERPRI L MANIPALHOS 90,425.61 102.72 5.49 12.95 13.93
Aster DM Healthcare Ltd. ASTERDM 63,640.8 136.94 8.66 13.07 16.22
Fortis Healthcare Ltd. FORTIS 60,170.16 58.81 5.83 11.32 14.07

Jupiter Life Line Hospitals Ltd. (JLHL) has a P/E ratio of 49.38x compared with the displayed peer median of 73.2x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.39% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 15.7% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Jupiter Life Line Hospitals Ltd. (JLHL) has a market capitalisation of Rs 9,493.96 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Jupiter Life Line Hospitals

  • Jupiter Life Line Hospitals Share Price is up 9.7% today and is trading at the day’s high.
  • The stock has a market capitalisation of Rs 9,493.96 crore, which keeps JLHL visible in healthcare market news.
  • Its P/E of 49.38 and P/B of 5.65 give Jupiter Life Line Hospitals Share Price a defined valuation profile.
  • ROE at 13.39% and ROCE at 15.7% offer operating context for Jupiter Life Line Hospitals Fundamental Analysis.
  • The Healthcare sector and Hospital & Healthcare Services industry comparison helps frame Jupiter Life Line Hospitals Share Price rise today.

About Jupiter Life Line Hospitals

Jupiter Life Line Hospitals Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company’s market position is reflected in its Rs 9,493.96 crore market capitalisation, and its stock trades on NSE and BSE under the symbol JLHL. In company overview terms, Jupiter Life Line Hospitals Share Price represents a hospital business that investors often assess through financial ratios rather than broad market claims. The latest Univest figures show revenue context through the company’s listed financial metrics, while EPS of Rs 5.69, book value of Rs 49.73 and dividend yield of 0.07% add further structure to the picture. For anyone reviewing Jupiter Life Line Hospitals Stock Performance, the important point is that the business sits inside a regulated healthcare services segment where valuation and return ratios matter together. Jupiter Life Line Hospitals Latest News coverage is therefore best read alongside company financials, sector analysis and peer comparison.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Jupiter Life Line Hospitals Share Price rising today?

Ans. Jupiter Life Line Hospitals Share Price is rising today because the stock is up 9.7% and is trading at Rs 308.05. The price move is confirmed in Univest data; a company-specific reason has not been established.

What is Jupiter Life Line Hospitals Share Price today?

Ans. Jupiter Life Line Hospitals Share Price today is Rs 308.05. The stock is up Rs 27.25 from the previous close of Rs 280.8, and the market capitalisation stands at Rs 9,493.96 crore.

What was the previous close for JLHL Share Price?

Ans. The previous close for JLHL Share Price was Rs 280.8. The stock opened at Rs 281.35 and moved higher during the day, with the latest trade at Rs 308.05 as of 20 November 2026 at 1:23:03 PM IST.

What does Jupiter Life Line Hospitals Fundamental Analysis show?

Ans. Jupiter Life Line Hospitals Fundamental Analysis shows a P/E of 49.38, P/B of 5.65, ROE of 13.39%, ROCE of 15.7%, EPS of Rs 5.69 and book value of Rs 49.73. Dividend yield is 0.07%.

How does Jupiter Life Line Hospitals compare with healthcare peers?

Ans. Jupiter Life Line Hospitals Share Price sits with a P/E of 49.38, below Apollo Hospitals, Max Healthcare, Manipal Health and Aster DM, and above Narayana Hrudayalaya on the latest Univest peer list. Its ROE and ROCE are also mid-pack.

What is the market cap of Jupiter Life Line Hospitals?

Ans. Jupiter Life Line Hospitals has a market capitalisation of Rs 9,493.96 crore. In the same-industry benchmark, that is above the sector median market cap and below the sector average market cap.

Is Jupiter Life Line Hospitals part of NSE and BSE?

Ans. Yes, Jupiter Life Line Hospitals Share Price is tracked on NSE and BSE under JLHL. The stock belongs to the Healthcare sector and the Hospital & Healthcare Services industry, which helps frame today’s move.

What sector benchmark is relevant for Jupiter Life Line Hospitals?

Ans. The relevant benchmark is the same industry set of 65 companies in Hospital & Healthcare Services. Jupiter Life Line Hospitals Share Price can be compared against sector median P/E, P/B, ROE, ROCE and market cap figures.

Track Jupiter Life Line Hospitals Share Price on Univest

Use Jupiter Life Line Hospitals Ltd. (JLHL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Jupiter Life Line Hospitals Share Price on Univest for live price updates, valuation ratios, 52-week levels and market insights in one place. The platform also helps users review Jupiter Life Line Hospitals Share Price Today alongside sector benchmarks, peer comparisons and company financials. For JLHL Share Price Live monitoring, Univest keeps the key stock data together so investors can follow price action and fundamental analysis without switching between sources. Jupiter Life Line Hospitals Share Price update pages are useful for checking how the stock moves through the day and how the valuation compares with the healthcare universe.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply